Navigation Links
Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
Date:1/24/2013

Income, excluding items

$25.9

$32.6

(20.7%)

$82.7

$127.0

(34.9%)Operating Margin, excluding items

12.0%

13.9%9.6%

13.7%** Facilities closed in 2012 include Chandler, Honolulu and Basel.The Early Development segment includes preclinical toxicology, analytical chemistry, clinical pharmacology, discovery support, and research products.  Net revenues in the fourth quarter of 2012 declined 7.3% year-on-year on a GAAP basis to $217.4 million and 7.9% on a pro forma basis to $215.9 million, due to the following: declines in toxicology, discovery support, and clinical pharmacology; the impact of the sale of environmental services (which had contributed approximately $2.0 million in quarterly revenue); and the closure of sites in 2012. In the quarter, foreign exchange had a 20 basis point year-on-year favorable impact. Sequentially, pro forma revenues decreased $1.9 million on a decline in discovery support. Toxicology revenues were flat sequentially.

GAAP operating income in the fourth quarter of 2012 was $18.7 million, and included $4.3 million in costs associated with our on-going restructuring actions and $2.9 million in losses at closed facilities. GAAP operating income for the fourth quarter of 2011 was $17.7 million, and included $15.0 million in restructuring costs.  Pro forma operating income, excluding these items, was $25.9 million in the fourth quarter of this year, versus $26.9 million last quarter and $32.6 million in the fourth quarter of 2011. Pro forma operating margins were 12.0% for the fourth quarter of this year, versus 12.4% last quarter and compared to 13.9% in the fourth quarter of 2011. Sequentially, pro forma operating income decreased primarily due to a decline in profitability in discovery support.  

Late-Stage Development($ in millions)4Q124Q11ChangeFY12FY11ChangeNet Revenues

$344.8

$298.0

15.7%'/>"/>

SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Covance To Present At The William Blair 32nd Annual Growth Stock Conference
2. Covance Reports Second Quarter Pro Forma Net Revenue Of $538 Million, Pro Forma EPS Of $0.65 And Adjusted Net Orders Of $701 Million
3. Covance to Present at the Morgan Stanley Global Healthcare Conference
4. Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million
5. Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
6. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
7. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
8. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
9. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
10. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
11. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 26, 2015  LabStyle Innovations Corp. (DRIO), ... announced today that in partnership with ... Healthcare, it has launched  the comprehensive Dario™ ... advanced Telecare unit (MOMA). The Dario™ is ... enables remote treatment for diabetes aiming to ...
(Date:5/26/2015)... Mass. , May 26, 2015 Boston Scientific ... the Goldman Sachs 36 th Annual Global Healthcare Conference ... Dan Brennan , executive vice ... vice president, Investor Relations, will participate in a 35-minute question ... beginning at approximately 10 a.m. PT. A live ...
(Date:5/26/2015)... Mast Therapeutics, Inc. (NYSE ... molecular adhesion and sealant technology (MAST) platform to ... failure, and arterial disease, today reported that it ... study of vepoloxamer (MST-188) in sickle cell disease, ... patients who have completed the Company,s Phase 3 ...
Breaking Medicine Technology:LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 2LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 3LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 4Boston Scientific To Participate In The Goldman Sachs 36th Annual Global Healthcare Conference 2Mast Therapeutics Announces Initiation Of EPIC-E Study 2Mast Therapeutics Announces Initiation Of EPIC-E Study 3Mast Therapeutics Announces Initiation Of EPIC-E Study 4Mast Therapeutics Announces Initiation Of EPIC-E Study 5
... , SANTA MONICA, Calif. , March 18 ... of Derycz Scientific, Inc., (OTC Bulletin Board: DYSC), a ... the flow of information from content publishers to enterprise ... journals Pharmaceutical Manufacturing and Genetic Engineering ...
... , CINCINNATI , March 17 Kendle (Nasdaq: ... announced Dr. Ross Horsburgh , Vice President, Asia/Pacific ... March 17-18, 2010 at the Raffles City Convention Centre ... in Asia ," is scheduled for March 18 ...
Cached Medicine Technology:Derycz Scientific Featured in Pharmaceutical Manufacturing and Genetic Engineering & Biotechnology News 2Derycz Scientific Featured in Pharmaceutical Manufacturing and Genetic Engineering & Biotechnology News 3Derycz Scientific Featured in Pharmaceutical Manufacturing and Genetic Engineering & Biotechnology News 4Kendle Executive to Share Insights at World Pharma Trials Asia 2010 2Kendle Executive to Share Insights at World Pharma Trials Asia 2010 3
(Date:5/26/2015)... NC (PRWEB) May 26, 2015 ... compliance solutions for the health and human services market, ... to meet demand. After strong attendance and participation in ... groups, and give their annual user conference an exciting ... Relias customers to come together and discuss best practices, ...
(Date:5/26/2015)... MD (PRWEB) May 26, 2015 ... marijuana. According to an article published by ... synthetic marijuana (dubbed K2, Spice, and black mamba) ... composition of these synthetic substances make it nearly ... confirm patients’ use of the substance due to ...
(Date:5/26/2015)... 26, 2015 Pasadena porcelain veneers ... dental cleanings with cosmetic treatments. Cosmetic dentistry is becoming ... Dentistry , “We are committed to providing you with ... outstanding customer service and a smile of a lifetime ... your smiles but to change your life,” explains Dr. ...
(Date:5/26/2015)... Indosoft, Inc ., developer of ... DMi Partners contact center to Q-Suite 5.8 ... Indosoft's contact center ACD system to drop Asterisk 1.4 ... such trunk features as diversion headers, added Lyra support ... upgrades to warm transfers to improve information ...
(Date:5/26/2015)... May 26, 2015 National Prevention Week ... year. It is supported by the Substance Abuse ... raising public awareness of, and action about, substance abuse ... organizations and coalitions are encouraged to join in promoting ... and related issues, and in building community partnerships. , ...
Breaking Medicine News(10 mins):Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 2Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 3Health News:Pasadena Porcelain Veneers Expert, Marine Martirosyan DDS, is Now Offering Complimentary Dental Cleaning with Cosmetic Treatments 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3Health News:Narconon Arrowhead Takes Part in National Prevention Week 2Health News:Narconon Arrowhead Takes Part in National Prevention Week 3
... ... Speaks at Gladys B. Jacobs Manor, in North Central Philadelphia , ... Philadelphia, PA (Vocus) October 28, 2009 ... Latina ever appointed to that position, recently spoke at the Original Richard Allen Committee’s ...
... /PRNewswire/ - LPBP Inc. (the "Company") announces a ... related to the per share dividend payable on ... dividend on the Class B Non-Voting shares should ... A Common shares of $0.0099 per share remains ...
... Oct. 28 In response to rising suicide and ... dedicated to supporting marriages and families, will present its ... to military couples in Milwaukee from Nov. 6 - 8 ... Weekend to Remember is a marriage getaway aimed ...
... California religious and community leaders, who have witnessed first ... well as the homeless, sick and mentally ill, gathered ... legalizing marijuana sales and use in California. , ... numerous faiths and religious denominations, were joined by community ...
... in tissue damage caused by smoking , WEDNESDAY, Oct. ... therapy for injured lungs that were previously rejected for ... transplant, researchers say. , Successful transplants require healthy lungs, ... highly inflamed and only mildly functional, which means many ...
... 28 If we get a boo-boo, we might know to ... kiss it and make it all better. But, what if ... us who aren,t prepared for dental emergencies can quickly get back ... Company at: , http://inr.mediaseed.tv/oneClip_C/?feed=Ss8P5Rb1iQulYDAELUR0M_kpwKp_6YSM , Medialink ...
Cached Medicine News:Health News:Head of PA Department of Aging Speaks at the Richard Allen Committee's 17th Annual Senior Citizen's Event 2Health News:FamilyLife Supports Military Marriages in Milwaukee 2Health News:Faith-Based Leaders and Community Activists Converge on State Capitol to Oppose Legalized Marijuana 2Health News:Faith-Based Leaders and Community Activists Converge on State Capitol to Oppose Legalized Marijuana 3Health News:Repairing Injured Lungs May Boost Organ Donations 2
... Cell-Chex is a spinal and body fluid ... When stained in the same manner as ... can be differentiated. The two-level control is ... white blood cell differential, as well as ...
... is a gene expression ... the risk of metastasis ... It is based on ... the Netherlands Cancer Institute ...
Antelys Peek Lumbar Technologies provides a range of varied heights and angles to correct lumbar lordosis and the associated sagital balance....
Abiomed introduces its new intra-aortic balloon (IAB); an easy-to-insert, minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart...
Medicine Products: